Shows L-MA improves intestinal health by enhancing stem cell activity and barrier function, suggesting a new treatment strategy.
The continuous proliferation and differentiation of intestinal stem cells are essential for maintaining homeostasis and barrier function. l-Malic acid (L-MA), a key intermediate in host and microbial metabolism, has emerged as a potential regulator of intestinal health. In this study, oral administration of L-MA improved intestinal structure and barrier function and the activity of intestinal stem cells. Mechanistically, L-MA reduced intracellular NAD+ levels, which in turn inhibited the expression and enzymatic activity of Sirt2. This further enhanced the acetylation and activation of β-catenin, thereby upregulating the expression of ZO-1, PCNA, Occludin, and Claudin1. Using a small intestinal organoid model, we confirmed that L-MA increased organoid budding rate and formation efficiency and inhibited Sirt2 expression. In conclusion, L-MA regulates ISC expansion and improves intestinal barrier function by modulating NAD+ levels via the Sirt2/β-catenin signaling pathway. These findings provide a novel strategy for maintaining intestinal health by targeting intestinal epithelial cell homeostasis.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: